000			01574 a2200409 4500
005			20250514030751.0
264		0	_c20020612
008			200206s 0 0 eng d
022			_a0165-2427
024	7		_a10.1016/s0165-2427(01)00426-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aArai, Maki
245	0	0	_aIs AZT/3TC therapy effective against FIV infection or immunopathogenesis? _h[electronic resource]
260			_bVeterinary immunology and immunopathology _cMar 2002
300			_a189-204 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aAnti-HIV Agents _xadverse effects
650	0	4	_aAntibodies, Viral _xblood
650	0	4	_aCD4-Positive T-Lymphocytes _ximmunology
650	0	4	_aCD8-Positive T-Lymphocytes _ximmunology
650	0	4	_aCat Diseases _xdrug therapy
650	0	4	_aCats
650	0	4	_aDrug Synergism
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFeline Acquired Immunodeficiency Syndrome _xdrug therapy
650	0	4	_aFlow Cytometry
650	0	4	_aImmunodeficiency Virus, Feline _xgenetics
650	0	4	_aLamivudine _xadverse effects
650	0	4	_aRandom Allocation
650	0	4	_aViral Load _xveterinary
650	0	4	_aZidovudine _xadverse effects
700	1		_aEarl, Donald D
700	1		_aYamamoto, Janet K
773	0		_tVeterinary immunology and immunopathology _gvol. 85 _gno. 3-4 _gp. 189-204
856	4	0	_uhttps://doi.org/10.1016/s0165-2427(01)00426-3 _zAvailable from publisher's website
999			_c11846683 _d11846683